LABT - Lakewood-Amedex Biotherapeutics Announces IRB Approval and Clinical Site Readiness to Initiate Phase 2a Clinical Trial of Nu-3 for the Treatment of Infected Diabetic Foot Ulcers
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.